XML 90 R78.htm IDEA: XBRL DOCUMENT v3.25.3
STOCK-BASED COMPENSATION - Schedule of Option Activity (Details) - Options - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Compensation expense, Total $ 6,669 $ 6,285
Compensation expense, net of tax 5,455 6,121
Grant date fair value of options vested 5,200 2,306
Compensation expense (included in SG&A)    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Compensation expense, Total 6,082 5,678
Compensation expense (included in Cost of sales)    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Compensation expense, Total $ 587 $ 607
Stock Awards Plans    
Assumptions used to estimate fair value of stock options granted    
Dividend Yield 1.17% 1.28%
Expected Stock Price Volatility 17.66% 17.03%
Risk-free interest rate 4.21% 4.51%
Expected Life of Option (years) 7 years 7 years
Stock options activity    
Outstanding at the beginning of the period (in shares) 1,663,307  
Granted (in shares) 226,187  
Exercised (in shares) (194,834)  
Forfeited or expired (in shares) (13,671)  
Outstanding at the end of the period (in shares) 1,680,989  
Stock option weighted average exercise price    
Outstanding at the beginning of the period (in dollars per share) $ 93.69  
Options granted, Weighted average exercise price (in dollars per share) 147.84  
Options exercised, Weighted average exercise price (in dollars per share) 76.20  
Options forfeited or expired, Weighted average exercise price (in dollars per share) 114.87  
Outstanding at the end of the period (in dollars per share) $ 102.83  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Options exercisable, Number of options (in shares) 1,195,724  
Options exercisable, Weighted average exercise price (in dollars per share) $ 88.11  
Options outstanding, Weighted average remaining contractual term 4 years 6 months  
Options exercisable, Weighted average remaining contractual term 2 years 9 months 18 days  
Options outstanding, Aggregate intrinsic value $ 54,546  
Options exercisable, Aggregate intrinsic value 53,009  
Options exercised, Intrinsic value, at end of period $ 15,079 $ 43,779